NRG Therapeutics raised €58M in a Series B round in Sep 2025. The company is based in Cambridge, UK. Investors in the round: Brandon Capital, British Business Bank, Criteria Bio Ventures and 4 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
